Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:02 PM
Ignite Modification Date:
2025-12-24 @ 2:02 PM
NCT ID:
NCT00003795
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically confirmed early stage ovarian and endometrial cancer survivors treated and diagnosed five or more years ago
* Patients completing treatment in GOG-95 or GOG-99 protocols at least 5 years ago with no recurrence of disease
* Patients with secondary malignancy or under treatment for other medical conditions are eligible
PATIENT CHARACTERISTICS:
Age:
* Not specified
Performance status:
* Not specified
Life expectancy:
* Not specified
Hematopoietic:
* Not specified
Hepatic:
* Not specified
Renal:
* Not specified
Other:
* Must be capable of completing telephone interview in English
PRIOR CONCURRENT THERAPY:
Biologic therapy:
* See Disease Characteristics
Chemotherapy:
* See Disease Characteristics
Endocrine therapy:
* See Disease Characteristics
Radiotherapy:
* See Disease Characteristics
Surgery:
* See Disease Characteristics
Healthy Volunteers:
False
Sex:
FEMALE
Study:
NCT00003795
Study Brief:
Protocol Section:
NCT00003795